We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice for medical professionals to follow when assessing drivers with neurological disorders.
Use the ESDAL system to plot your route when transporting abnormal loads
Safety leaflet to help you understand the latest information about the effects of pregabalin during pregnancy.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
How to assess young women with abnormal vaginal bleeding, in a clinical or primary care setting.
Advice for medical professionals to follow when assessing drivers with drug or alcohol misuse or dependence.
Advice for medical professionals to use when assessing drivers with cardiovascular disorders.
What UK goods vehicle operators need to do to carry out international road haulage.
Information on the programme, including commissioning, quality assurance, education and training.
You must notify Roads Service to transport an abnormal load by road in Northern Ireland
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.